Initial exposed phosphatidylserine levels correlate with cellular response to cytotoxic drugs

European Journal of Haematology

Volumn 70, Issue 2, 2003, Pages 98-105

  Drucker, Liat ^a   Ciobotaro, Pnina ^a   Kimchi, Oded ^a   Tohami, Tali ^a   Yarkoni, Shai ^a   Radnay, Judith ^a   Shapira, Hava ^a   Lishner, Michael ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

5 fluorouracil; Apoptosis; Doxorubicin; Leukocytes

Indexed keywords

5' FLUOROURACIL; ANTINEOPLASTIC AGENT; CD18 ANTIGEN; CD63 ANTIGEN; CYTOTOXIC AGENT; DOXORUBICIN; FAS ANTIBODY; GLYCOPROTEIN P 15095; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PHOSPHATIDYLSERINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOASSAY; BLOOD LEVEL; BREAST CARCINOMA; CELL SUBPOPULATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE MARKER; DRUG INFUSION; DRUG RESPONSE; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE; LEUKOPENIA; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CELL MEMBRANE; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LEUKOCYTES; LEUKOPENIA; MALE; MIDDLE AGED; PHOSPHATIDYLSERINES;

EID: 0037331222     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2003.00019.x     Document Type: Article

References (31)

1. KAGAN VE, FABISIAK JP, SHVEDOVA AA, TYURINA YY, SCHOR NF, KAWAI K. Oxidative signaling pathway for externalization of plasma membrane phosphatidylserine during apoptosis. FEBS Lett 2000;477:1-7.
2. 2+ responses. Blood 1997;90:2615-2625.
3. FADOK VA, DE CATHELINEAU A, DALEKE DL, HENSON PM, BRATTON DL, Loss of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J Biol Chem 2001;276:1071-1077.
4. SCHROIT AJ, ZWAAL RFA. Transbilayer movement of phopholipids in red cell and platelet membranes. Biochim Biophys Acta 1991;1071:313-329.
5. ZWAAL RFA, SCHROIT AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997;89:1121-1132.
6. TYURINA YY, SHVEDOVA AA, KAWAI K, TYURIN VA, KOMMINENI C, QUINN PJ, SCHOR NF, FABISIAK JP, KAGAN VE. Phospholipid signaling in apoptosis: peroxidation and externalization of phosphatidylserine. Toxicology 2000;148:93-101.
7. PELASSY C, BREITTMAYER JP, AUSSEL C. Regulation of phosphatidylserine exposure at the cell surface by serine-base exchange enzyme system during CD95-induced apoptosis. Biochem Pharmacol 2000;59:855-863.
8. PIKE LJ, HAN X, CHUNG KN, GROSS RW. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is dependent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry 2002;41:2075-2088.
9. POHL A, LAGE H, MULLER P, POMORSKI T, HERMANN A. Transport of phosphatidylserine via MDR1 (multidrug resistance 1) P-glycoprotein in a human gastric carcinoma cell line. Biochem J 2002;365:259-268.
10. BOW EJ. Infection risk and cancer chemotherapy: the impact of the chemotherapuetic regimen in patients with lymphoma and solid tissue malignancies (suppl.). J Antimicrob Chemother 1998;41 (suppl.):1-5.
11. BOYUM A. Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents. Scand J Clin Lab Invest 1968;97 (suppl.):31-50.
12. SGONC R, GRUBER J. Apoptosis detection: an overview. Exp Gerontol 1998;33:525-533.
13. CARBONARI M, CIBATI M, CHERCHI M, SBARIGIA D, PESCE AM, DELLWANNA L, MODICA A, FIORILLI M. Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus infection and cancer chemotherapy by a novel flow immunocytometric method. Blood 1994;83:1268-1277.
14. DARZYNKIEWICZ Z, BEDNER E, SMOLEWSKI P. Flow cytometry in analysis of cell cycle and apoptosis. Semin Hematol 2001;38:179-193.
15. FADOK VA, VOELKER DR, CAMPBELL PA, COHEN JJ, BRATTON DL, HENSON PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992;148:2207-2216.
16. ZHUANG J, REN Y, SNOWDEN RT, ZHU H, GOGVADZE V, SAVILL JS, COHEN GM. Dissociation of phagocyte recognition of cells undergoing apoptosis from other features of the apoptotic program. J Biol Chem 1998;273:15628-15632.
17. FADEEL B, AHLIN A, HENTER J-I, ORRENIUS S, HEMPTON MB. Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood 1998;92:4808-4818.
18. BRATTON DL, FADOK VA, RICHTER DA, KAILEY JM, GUTHRIE LA, HENSON PM. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J Biol Chem 1997;272: 26159-26165.
19. FADEEL B, GLEISS B, HOGSTRAND K, CHANDRA J, WIEDMER T, SIMS PJ, HENTER J-I, ORRENIUS S, SAMALI A. Phosphatidylserine exposure during apoptosis is a cell-type-specific event and does not correlate with plasma membrane phospholipids scramblase expression. Bichem Biophys Res Commun 1999;266:504-511.
20. WIEGAND UK, CORBACH S, PRESCOTT AR, SAVILL J, SPRUCE BA. The trigger to cell death determines the efficiency with which dying cells are cleared by neighbors. Cell Death Differ 2001;8:734-746.
21. YANG M-Y, CHUANG H, CHEN R-F, YANG KD. Reversible phosphatidylserine expresion on blood granulocytes related to membrane pertubation but not DNA strand breaks. J Leukoc Biol 2002;71:231-237.
22. TAIT JF, SMITH C, WOOD BL. Measurement of phosphatidylserine exposure in leukocytes and platelets by whole blood flow cytometry with annexin V. Blood Cells Mol Dis 1999;25:271-278.
23. UTSUGI T, SCHROIT AJ, CONNOR J, BUCANA CD, FIDLER IJ. Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 1991;51:3062-3066.
24. BEVERS EM, COMFURIUS P, DEKKERS DWC, HARMSMA M, ZWAAL RFA. Transmembrane phospholipids distribution in blood cells: control mechanisms and pathophysiological significance. Biol Chem 1998;379:973-986.
25. ZHAO J, ZHOU Q, WIEDMER T, SIMS P. Level of expression of phospholipid scramblase regulates induced movement of phosphatidylserine to the cell surface. J Biol Chem 1998;273:6603-6606.
26. SPEELMANS G, STAFFHORST RW, DE KRUIJFF B, DE WOLF FA. Transport studies of doxorubicin in model membranes indicate a difference in passive diffusion across and binding at the outer and inner leaflets of the plasma membrane. Biochemistry 1994;33:13761-13768.
27. BANDROWICZ-PIKULA J. Lipid-binding proteins as stabilizers of membrane microdomains - possible physiological significance. Acta Biochem Pol 2000;47:553-564.
28. DILLON SR, MANCINI M, ROSEN A, SCHLISSEL MS. ANNEXIN V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation. J Immunol 2000;164:1322-1332.
29. GRASSME H, JEKLE A, RIECHLE A, SCHWARTZ H, BERGER J, SANDHOFF K, KOLESNICK R, GULBINS E. CD95 signaling via ceramide-rich membrane rafts. J Biol Chem 2001;276:20589-20596.
30. KAMBIRA S, YAMADA Y, HIRAKATA Y, TSURUDA K, SUGAHARA K, TOMONAGA M, MAEDA T, TSUKASAKI K, ATOGAMI S, KOBAYASHI N. Quantitative characterization and potential function of membrane Fas/APO-1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukemias. Br J Haematol 1997;99:858-865.
31. SELLERI C, MACIEJEWSKI JP, PANE F, LUCIANO L, RAIOLA AM, MOSTARDA L, SALVATORE F, ROTOLI B. Fas-mediated modulation of Bcr/Abl in chronic myelogenous leukemia results in differential effects on apoptosis. Blood 1998;92:981-989.